Questions about cBioPortal

21 views
Skip to first unread message

Victoria Tomaz

unread,
Oct 28, 2024, 1:01:22 PM10/28/24
to cbiop...@googlegroups.com, Paulo Vidal Campregher
Hi everyone

My name is Victoria Tomaz and I am a PhD student at Hospital Israelita Albert Einstein at São Paulo - Brazil

I am using cBioPortal to develop my PhD project. I have already watched your tutorials, but I still have some questions. They are below:

1. In addition to the API as a tool to access your data, is it possible for me to create my own data tables on your website and work online?

2. When I download all the patients/samples that have a mutation in a gene X from the "Mutations" tab, there is a column referring to the OncoKB classification. When I use your API, I am unable to download this information about the OncoKB classification for each of the variants. Could you help me with this problem?

3. Furthermore, I would like to know how you treat benign variants in the samples, since the tables I download only show oncogenic variants, probably oncogenic and of uncertain significance (according to the OncoKB classification). How can I find out the number and benign variants found in each patient in the studies?

If we can schedule a meeting to talk about the platform, it would be very helpful!

If you have any courses available on cBioPortal, I would like to take one too! To learn about all the tools available on the site and how I can manage my data and analyze it there.

Thank you in advance and I look forward to hearing from you!


Best Regards

Victória Tomaz
Biomédica, Doutorada em Ciências da Saúde
Instituto Israelita de Ensino e Pesquisa Albert Einstein 

Esta mensagem contem informacao confidencial e/ou privilegiada. Se voce nao for o destinatario ou a pessoa autorizada a receber esta mensagem, nao pode usar, copiar ou divulgar as informacoes nela contidas ou tomar qualquer acao baseada nessas informacoes. Se voce recebeu esta mensagem por engano, por favor avise imediatamente o remetente, respondendo o e-mail e em seguida apague-o. Comunicacoes pela Internet nao podem ser garantidas quanto a pontualidade, seguranca ou inexistencia de erros ou virus. O remetente por esta razao nao se responsabiliza por qualquer erro, omissao ou mesmo opinioes e declaracoes contidas no conteudo desta mensagem. This E-mail is confidential. It may also be legally privileged. If you are not the addressee you may not copy, forward, disclose or use any part of it. If you have received this message in error, please delete it and all copies from your system and notify the sender immediately by return E-mail. Internet communications cannot be guaranteed to be timely, secure, error or virus-free. The sender does not accept liability for any errors, omissions, opinions or declarations contained in this E-mail.

Tali Mazor

unread,
Oct 28, 2024, 4:13:56 PM10/28/24
to Victoria Tomaz, cbiop...@googlegroups.com, Paulo Vidal Campregher
Hi Victoria,

Thanks for reaching out. I will try to address all your questions.

1) If you want to supplement an existing study with additional data, you can do so using the Custom Data option in the Charts menu in study view. This allows you to add sample or patient level attributes to an existing study (see screenshot below). Note that you will have to log in to the site in order to take advantage of this feature.
image.png

If you have your own complete dataset, you can set up your own instance of cBioPortal locally or utilize our OncoPrint & MutationMapper: https://www.cbioportal.org/visualize

2) You can use the OncoKB API or the OncoKB Annotator (https://www.oncokb.org/api-access) to annotate data with OncoKB classification.

3) There are some mutation types (eg synonymous mutations, see https://docs.cbioportal.org/file-formats/#variant-classification-filter) which are not imported into cBioPortal, but beyond that all variants are treated the same. cBioPortal ingests variants as they were called in the original publication and it's always possible that the original publication had some filtering steps -- in which case I'd suggest referring back to the methods section of the original publication for your study of interest.

-Tali


--
You received this message because you are subscribed to the Google Groups "cBioPortal for Cancer Genomics Discussion Group" group.
To unsubscribe from this group and stop receiving emails from it, send an email to cbioportal+...@googlegroups.com.
To view this discussion visit https://groups.google.com/d/msgid/cbioportal/CPUP152MB5132CF6DB4D242CC699DBF0C9D4A2%40CPUP152MB5132.LAMP152.PROD.OUTLOOK.COM.
Reply all
Reply to author
Forward
0 new messages